Literature DB >> 20158336

Recent findings regarding maintenance of enzootic variants of Yersinia pestis in sylvatic reservoirs and their significance in the evolution of epidemic plague.

Scott W Bearden1, Robert R Brubaker.   

Abstract

Despite the widespread presence of bubonic plague in sylvatic reservoirs throughout the world, the causative agent (Yersinia pestis) evolved in its present form within the last 20,000 years from enteropathogenic Yersinia pseudotuberculosis. Comparison of the genomes from the two species revealed that Y. pestis possesses only a few unique plasmid-encoded genes that contribute to acute disease, whereas this organism has lost about 13% of the chromosomal genes that remain active in Y. pseudotuberculosis. These losses reflect readily detectable additions, deletions, transpositions, inversions, and acquisition of about 70 insertion sequence (IS) inserts, none of which are likely to promote increased virulence. In contrast, major enzymes of intermediary metabolism, including glucose 6-phosphate dehydrogenase (Zwf ) and aspartase, are present but not catalytically functional due to the presence of missense mutations. The latter are generally not detectable by the technology of bioinformatics and, in the case of Y. pestis, result in radical changes in the metabolic flow of carbon. As an important consequence, plague bacilli exhibit a stringent low-calcium response characterized by conversion of L-glutamate (and metabolically related amino acids) to L-aspartate with secretion of the latter into supernatant fluid at 37 degrees C in culture media containing Na(+) but lacking added Ca(2+). This phenomenon also occurs in vivo and likely adversely affects the bioenergetics of host amino acid pools. Curiously, aspartase is functional in all tested enzootic (pestoides) strains of Y. pestis. These isolates are typically restricted to the ancient plague reservoirs of Central Asia and Africa and are fully virulent in members of the rodent Superfamily Muroidea but avirulent in guinea pigs and man. The implications of these findings for the distribution and ecology of Y. pestis could be significant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20158336      PMCID: PMC2945867          DOI: 10.1089/vbz.2009.0043

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  71 in total

1.  Dideoxysugars of Pasteurella pseudotuberculosis-specific polysaccharides, and the occurrence of ascarylose.

Authors:  D A DAVIES
Journal:  Nature       Date:  1961-07-01       Impact factor: 49.962

Review 2.  [The basic features of the pathogenesis of pseudotuberculosis (yersiniosis)].

Authors:  A P Avtsyn; L M Isachkova; A A Zhavoronkov; G P Somov; M V Makhnev
Journal:  Arkh Patol       Date:  1990

3.  Increased virulence of Yersinia pseudotuberculosis by two independent mutations.

Authors:  R Rosqvist; M Skurnik; H Wolf-Watz
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 4.  [Plasmids of the pathogenicity of Yersinia pestis].

Authors:  V V Kutyrev; Iu A Popov; O A Protsenko
Journal:  Mol Gen Mikrobiol Virusol       Date:  1986-06

5.  Essential virulence determinants of different Yersinia species are carried on a common plasmid.

Authors:  R Ben-Gurion; A Shafferman
Journal:  Plasmid       Date:  1981-03       Impact factor: 3.466

6.  Quantitative competitive PCR as a technique for exploring flea-Yersina pestis dynamics.

Authors:  D M Engelthaler; B J Hinnebusch; C M Rittner; K L Gage
Journal:  Am J Trop Med Hyg       Date:  2000-05       Impact factor: 2.345

Review 7.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Consequences of Ca2+ deficiency on macromolecular synthesis and adenylate energy charge in Yersinia pestis.

Authors:  R J Zahorchak; W T Charnetzky; R V Little; R R Brubaker
Journal:  J Bacteriol       Date:  1979-09       Impact factor: 3.490

9.  Consequences of aspartase deficiency in Yersinia pestis.

Authors:  L A Dreyfus; R R Brubaker
Journal:  J Bacteriol       Date:  1978-11       Impact factor: 3.490

Review 10.  The recent emergence of plague: a process of felonious evolution.

Authors:  R R Brubaker
Journal:  Microb Ecol       Date:  2004-03-25       Impact factor: 4.552

View more
  6 in total

Review 1.  An additional step in the transmission of Yersinia pestis?

Authors:  W Ryan Easterday; Kyrre L Kausrud; Bastiaan Star; Lise Heier; Bradd J Haley; Vladimir Ageyev; Rita R Colwell; Nils Chr Stenseth
Journal:  ISME J       Date:  2011-08-11       Impact factor: 10.302

Review 2.  Evaluation of Yersinia pestis Transmission Pathways for Sylvatic Plague in Prairie Dog Populations in the Western U.S.

Authors:  Katherine L D Richgels; Robin E Russell; Gebbiena M Bron; Tonie E Rocke
Journal:  Ecohealth       Date:  2016-05-27       Impact factor: 3.184

3.  Early emergence of Yersinia pestis as a severe respiratory pathogen.

Authors:  Daniel L Zimbler; Jay A Schroeder; Justin L Eddy; Wyndham W Lathem
Journal:  Nat Commun       Date:  2015-06-30       Impact factor: 14.919

Review 4.  Interrelationship between type three secretion system and metabolism in pathogenic bacteria.

Authors:  Gottfried Wilharm; Christine Heider
Journal:  Front Cell Infect Microbiol       Date:  2014-10-27       Impact factor: 5.293

Review 5.  Omics strategies for revealing Yersinia pestis virulence.

Authors:  Ruifu Yang; Zongmin Du; Yanping Han; Lei Zhou; Yajun Song; Dongsheng Zhou; Yujun Cui
Journal:  Front Cell Infect Microbiol       Date:  2012-12-13       Impact factor: 5.293

6.  Comparative Proteomic Studies of Yersinia pestis Strains Isolated from Natural Foci in the Republic of Georgia.

Authors:  Maia Nozadze; Ekaterine Zhgenti; Maia Meparishvili; Lia Tsverava; Tamar Kiguradze; Gvantsa Chanturia; Giorgi Babuadze; Merab Kekelidze; Lela Bakanidze; Tatiana Shutkova; Paata Imnadze; Stephen C Francesconi; Richard Obiso; Revaz Solomonia
Journal:  Front Public Health       Date:  2015-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.